Form 8-K - Current report:
SEC Accession No. 0001387131-19-006142
Filing Date
2019-08-14
Accepted
2019-08-14 16:15:04
Documents
2
Period of Report
2019-08-14
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 CURRENT REPORT nbse-8k_081419.htm 8-K 22978
2 PRESS RELEASE ISSUED AUGUST 14, 2019 ex99-1.htm EX-99.1 22998
  Complete submission text file 0001387131-19-006142.txt   47361
Mailing Address 700 TECHNOLOGY DRIVE PITTSBURGH PA 15219
Business Address 700 TECHNOLOGY DRIVE PITTSBURGH PA 15219 6464501790
NeuBase Therapeutics, Inc. (Filer) CIK: 0001173281 (see all company filings)

EIN.: 465622433 | State of Incorp.: DE | Fiscal Year End: 0930
Type: 8-K | Act: 34 | File No.: 001-35963 | Film No.: 191026528
SIC: 2834 Pharmaceutical Preparations